Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 4, pp. 446-459
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 4, 2015
- Revision received January 12, 2016
- Accepted January 15, 2016
- Published first January 19, 2016.
Article Versions
- Previous version (January 19, 2016 - 06:41).
- You are viewing the most recent version of this article.
Copyright & Usage
©2016 American Association for Cancer Research.
Author Information
- Stephen J. Blake1,
- Kimberley Stannard2,
- Jing Liu1,2,
- Stacey Allen1,
- Michelle C.R. Yong1,
- Deepak Mittal2,
- Amelia Roman Aguilera2,
- John J. Miles3,4,
- Viviana P. Lutzky3,
- Lucas Ferrari de Andrade2,
- Ludovic Martinet2,
- Marco Colonna5,
- Kazuyoshi Takeda6,
- Florian Kühnel7,
- Engin Gurlevik7,
- Günter Bernhardt8,
- Michele W.L. Teng1,9 and
- Mark J. Smyth2,9,*
- 1Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
- 2Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
- 3Human Immunity, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
- 4Institute of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
- 5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
- 6Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
- 7Department for Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
- 8Institute of Immunology, Hannover Medical School, Hannover, Germany.
- 9School of Medicine, The University of Queensland, Herston, Queensland, Australia.
- ↵*Corresponding Author:
Mark J. Smyth, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston 4006, Australia. Phone: 61-7-3845-3957; Fax: 61-7-3362-0111; E-mail: mark.smyth{at}qimrberghofer.edu.au
April 2016
Volume 6, Issue 4
Volume 6, Issue 4
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Jump to section
Advertisement